Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 17, 2023
Catalent, Inc. announced the appointment of Ricardo Zayas as Senior Vice President, Operations, Biologics North America.
read more
Tuesday, January 17, 2023
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of Steve Yemm as Chief Commercial Officer (CCO), the latest in a series of senior-level hires as the Company rapidly expands.
read more
Thursday, January 12, 2023
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative’s Terra Carta Seal.
read more
Thursday, January 12, 2023
Charles River Laboratories International, Inc. announced the launch of its eXpDNA™ plasmid platform, established from the Company’s contract development and manufacturing (CDMO) and biologics testing experience.
read more
Thursday, January 12, 2023
Eurofins CDMO Alphora Inc. announced the relocation and expansion of its API development laboratories from 2395 Speakman Drive to its new, owned facility at 2070 Hadwen Road, located within the Sheridan Research Park in Mississauga, Ontario, Canada.
read more
Thursday, January 12, 2023
CordenPharma is pleased to announce the signing of a multi-year agreement commencing in 2023 for the contract manufacturing of a large-volume peptide at its CordenPharma Colorado facility.
read more
Thursday, January 12, 2023
lora Pharmaceuticals announced that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM, LLC's manufacturing capabilities located in Fort Worth, TX.
read more
Thursday, January 12, 2023
The IMA Group (IMA) has completed the acquisition of Clinical Trials of America (CTA), a multi-therapeutic clinical trials company that brings to IMA four new independent and six embedded site locations in Louisiana and North Carolina.
read more
Thursday, January 12, 2023
Catalent and Ethicann Pharmaceuticals Inc. announced that the companies have executed a development and license agreement to develop Ethicann’s clinical drug pipeline using Catalent’s proprietary Zydis® orally disintegrating tablet (ODT) technology.
read more
Thursday, January 12, 2023
Argonaut Manufacturing Services announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities.
read more
Tuesday, January 10, 2023
Avantor, Inc. has entered into a multi-year supply and services agreement with Catalent, Inc. enabling the development and supply of better treatments for patients worldwide.
read more
Tuesday, January 10, 2023
Kayentis and ClinOne announced a strategic alliance. This collaboration combines Kayentis’ expertise in clinical trial data collection with ClinOne’s best-in-class consent management and patient engagement technology.
read more
Tuesday, January 10, 2023
Sterling Pharma Solutions announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022.
read more
Tuesday, January 10, 2023
Ajinomoto Co., Inc. announced a license agreement with Exelixis, Inc. to incorporate AJICAP®, Ajinomoto Co.’s proprietary site-specific bioconjugation and linker technologies, in the development of certain of Exelixis’ antibody-drug conjugate (ADC) ...
read more
Tuesday, January 10, 2023
Qosina, a global supplier of OEM single- use components to the medical and pharmaceutical industries, is pleased to announce a partnership with ILC Dover, a leader in the innovative design and production of solutions for biopharmaceutical, ...
read more